William R Short, MD, MPH, AAHIVS
Perelman School of Medicine
University of Pennsylvania
Department of Medicine, Division of Infectious Diseases
Philadelphia, PA 19104
Hahnemann University, School of Allied Health Professions, 1986.
Hahnemann University School of Health Sciences and Professions, 1989.
Hahnemann University School of Medicine, 1997.
MPH (Epidemiology and Health Systems Policy)
UMDNJ School of Public Health, 2009.
Description of Clinical Expertisemanagement of HIV infection; management of pregnant women living with HIV; sexually transmitted infections.
Selected PublicationsPost FA, Tebas P, Clarke A, Cotte L, Short WR, Abram ME, Jiang S, Cheng A, Das M, Fordyce MW: Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. J Acquir Immune Defic Syndr 74(2): 180-184, Feb 2017.
Finocchario-Kessler S, Champassak S, Hoyt MJ, Short W, Chakraborty R, Weber S, Levison J, Phillips J, Storm D, Anderson J, and HIV PCC Study Team : Pre-Exposure Prophylaxis (PrEP) for Safer Conception Among Serodifferent Couples:Findings from Healthcare Providers Serving Patients with HIV in Seven US Cities. AIDS Patient Care STDs 30(3): 125, Mar 2016.
Rahangdale L, Cates J, Potter J, Badell ML, Seidman D, Miller ES, Coleman JS, Lazenby GB, Levison J, Short WR, Yawetz S, Ciaranello A, Livingston E, Duthely L, Rimawi BH, Anderson JR, Stringer EM: Integrase inhibitors in late pregnancy and rapid HIV viral load reduction. Am J Obstet Gynecol 214(3): 385, Mar 2016.
Joneja U, Short WR, Roberts AL: Disseminated tuberculosis with prostatic abscesses in an immunocompromised patient-A case report and review of literature. IDCases 5: 15-20, Jun 2016.
Truong WR, Schafer JJ, Short WR: Once-Daily, Single-Tablet Regimens For the Treatment of HIV-1 Infection. PT 40(1): 44-55, Jan 2015.
Miller C, Short WR, Perez-Povis L, Lontok J, Fecarotta C, Liu M, Sendecki J, Belden K: The spectrum of eye disease in hospitalized adults living with HIV, 1995-2010. AIDS Patient Care STDs 28(2): 47-55, Feb 2014.
Hodder S, Arasteh K, De Wet J, Gathe J, Gold J, Kumar P, Mohapi L, Short W, Crauwels H, Vanveggel S, Boven K: Effect of gender and race on the week 48 findings in treatment naive, HIV-1 infected patients enrolled in the randomized, phase III trials ECHO and THRIVE. HIV Med 13(7): 406-415, Aug 2012.
Scafer J, Short WR: Rilpivirine, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor for the Management of HIV-1 Infection. Antivir Ther 17(8): 1495-502, Aug 2012.